Michael Showalter joins Prime
This article was originally published in Scrip
Michael Showalter has joined Prime Therapeutics, a pharmacy benefit management company, as chief marketing officer. Mr Showalter previously served as senior vice-president of enterprise strategic planning at Cigna.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.